Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -15.26
- Piotroski Score 0.00
- Grade N/A
- Symbol (VAXX)
- Company Vaxxinity, Inc.
- Price $0.00
- Changes Percentage (0%)
- Change -$0
- Day Low $0.00
- Day High $0.00
- Year High $1.10
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.45
- Trailing P/E Ratio -0.2
- Forward P/E Ratio -0.2
- P/E Growth -0.2
- Net Income $-56,934
Income Statement
Quarterly
Annual
Latest News of VAXX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Chilling Warning From Cleveland Clinic: Wave of Mass Deaths Will Wipe Out Covid-Vaxxed Within '5 Years'
Cleveland Clinic warns of a potential wave of deaths within 5 years among Covid-vaccinated individuals due to myocarditis. Experts like Dr. Geert Vanden Bossche and Professor Dolores Cahill predict a ...
By The Washington Standard | 1 week ago -
RFK jr can sue Biden admin for allegedly censoring anti-vaxx posts...
A federal court ruled that Robert Kennedy Jr. can sue the Biden administration for allegedly censoring social media posts by the Children's Health Defense charity, questioning vaccine safety. The cour...
By New York Post | 3 months ago -
Meet the anti-vaxx millionaire donor behind congestion pricing and...
Hedge-funder Mark Gorton, a major donor to pro-congestion-pricing and transportation causes, also funds anti-vaccine conspiracy theories and supports Robert Kennedy Jr.'s campaign. Despite differing v...
By New York Post | 5 months ago
